beta Amyloid Antibody (AB9)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-50055
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Validated:
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Cited:
Immunohistochemistry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2A Clone # AB9
Concentration
1 mg/ml
Product Specifications
Immunogen
This beta Amyloid antibody was developed against amino acids 1-16 of human amyloid Abeta.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Theoretical MW
5 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for beta Amyloid Antibody (AB9)
Immunohistochemistry: beta Amyloid Antibody (AB9) [NBP2-50055]
Immunohistochemistry: beta Amyloid Antibody (AB9) [NBP2-50055] - Analysis of a region of cerebral cortex from an Alzheimer's disease (AD) patient stained with NBP2-50055, the signal detected with HRP and DAB. Senile plaques are labeled SP. The region of the lowest of the three plaques is shown in the inset stained with the fluorescent dye thioflavin-S. This dye binds to not only the senile plaque but also a neurofibrillary tangle (NFT), the other pathological hallmark of AD, which does not contain ABeta.Western Blot: beta Amyloid Antibody (AB9) [NBP2-50055]
Western Blot: beta Amyloid Antibody (AB9) [NBP2-50055] - Amyloid beta peptide blotted with NBP2-50055. NBP2-50055 recognizes amyloid beta peptide running at a molecular weight of 5 kDa and amyloid beta aggregates.Applications for beta Amyloid Antibody (AB9)
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
1:1000
Immunohistochemistry
1:1000
Western Blot
1:1000 - 1:2000
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50% PBS, 50% glycerol
Preservative
0.035% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Amyloid beta
Pyroglutamate amyloid beta peptides (pGlu-Abeta) are N-terminal truncations in which the N-terminal glutamate is cyclized to pyroglutamate resulting in pGlu-Abeta (3-40/42 and 11-40/42) (4). This pyrE modification may have a greater propensity to aggregate under physiological conditions and has been implicated as the molecular species responsible for seeding larger oligomers of amyloid beta.
References
1. Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE. (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 38(9):1205-1235. PMID: 28713158
2. De-Paula VJ1, Radanovic M, Diniz BS, Forlenza OV. (2012) Alzheimer's disease. Subcell Biochem. 65:329-52. PMID: 23225010
3. Schaich CL, Maurer MS, Nadkarni NK. (2019) Amyloidosis of the Brain and Heart: Two Sides of the Same Coin? JACC Heart Fail. 7(2):129-131. PMID: 30704604
4. He W, Barrow CJ. (1999) The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry. 38(33):10871-7. PMID: 10451383
Additional Amyloid beta Products
Product Documents for beta Amyloid Antibody (AB9)
Product Specific Notices for beta Amyloid Antibody (AB9)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...